BriefCase vs CLEWICU

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

BriefCase

by Aidoc Medical

CLEWICU

by Clew Medical

AI Verdict

BriefCase focuses on AI-powered communication and collaboration for critical medical *imaging* findings, primarily aiding radiologists in triage and notification of urgent cases from CT scans. In contrast, CLEWICU is an AI-driven clinical surveillance and predictive analytics platform that forecasts *patient deterioration* in high-acuity settings like the ICU, using a broad range of patient data beyond imaging. While both aim to improve patient outcomes through early detection and communication, their core data sources and clinical applications differ significantly.

Choose BriefCase if…

Choose BriefCase if your primary need is to streamline communication and collaboration around critical medical imaging findings. This tool excels at ensuring urgent radiology results are immediately shared with the relevant care team members, facilitating rapid decision-making and follow-up actions. Its integration with PACS, RIS, and EHR systems, along with customizable communication protocols, makes it ideal for large hospitals and health systems aiming to improve the efficiency and auditability of their imaging-related workflows.

View BriefCase →

Choose CLEWICU if…

Choose CLEWICU if your focus is on proactive clinical surveillance and predicting patient deterioration in high-acuity inpatient settings, such as ICUs. This platform leverages AI to provide early warnings of patient decline up to eight hours in advance, enabling timely interventions and potentially preventing adverse events. Its predictive analytics, customizable clinical protocols, and specialized virtual units for conditions like sepsis and heart failure make it well-suited for health systems looking to enhance patient safety and optimize critical care management.

View CLEWICU →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	BriefCase	CLEWICU
Pricing	Enterprise	Not publicly disclosed
Deployment	Cloud	Cloud, SaaS
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	1 AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

BriefCase

BriefCase offers a mobile app for both iOS and Android, enabling care teams to collaborate and receive critical alerts on the go. While CLEWICU has a web-based user interface and multi-patient dashboards, the explicit mention of mobile access for care team collaboration in BriefCase suggests a broader and more flexible approach to usability in various clinical settings.

Clinical Value

BriefCase

BriefCase, as part of the Aidoc platform, offers a wider range of FDA-cleared modules for various acute pathologies, including neurovascular emergencies, cardiopulmonary crises, and traumatic injuries, with over 31 FDA-cleared modules. CLEWICU focuses on predicting patient deterioration in critical care settings, specifically respiratory failure and hemodynamic instability, and has demonstrated high accuracy and reduced alarm fatigue. However, Aidoc's broader portfolio of cleared indications and extensive clinical validation (over 230 published studies or abstracts) suggests a more comprehensive clinical impact across different specialties.

Pricing & Value

Tie

Both tools utilize an enterprise pricing model, requiring custom quotes based on the size and scope of the health system. Neither company publicly discloses specific pricing details, making a direct comparison of value challenging.

Enterprise Readiness

BriefCase

BriefCase is integrated into the Aidoc platform, which is deployed in over 500 hospitals globally and offers seamless integration with PACS, RIS, and EHR systems. Aidoc also emphasizes its comprehensive regulatory compliance and adoption of AI transparency standards. While CLEWICU is also built for large enterprise deployments and is EHR-agnostic, Aidoc's larger customer count and explicit focus on a wide range of integrations suggest a more established enterprise readiness.

Innovation

Tie

Both tools demonstrate significant innovation in their respective domains. BriefCase leverages AI for critical finding detection and streamlined communication in medical imaging. CLEWICU utilizes AI-driven predictive analytics to forecast patient deterioration up to eight hours in advance, a crucial capability in critical care. Both are at the forefront of applying AI to improve healthcare workflows and patient outcomes.

Support & Docs

Tie

Both companies target large hospitals and health systems, implying a need for robust support and documentation for complex enterprise deployments. However, specific details regarding the depth and breadth of their support services and documentation are not explicitly provided for either tool in the given information or readily available through general web searches. Therefore, it is difficult to definitively pick a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	BriefCase	CLEWICU
Name	BriefCase	CLEWICU
Company	Aidoc Medical	Clew Medical
Description	Aidoc's BriefCase is an FDA-cleared AI-powered communication and collaboration solution integrated into the Aidoc platform, designed to streamline the sharing of critical medical imaging findings among care teams.	CLEWICU by Clew Medical is an FDA-cleared, AI-driven clinical surveillance and predictive analytics platform that predicts patient deterioration up to eight hours in advance, supporting high-acuity care across various inpatient settings.
Tagline	AI-driven communication and collaboration for critical medical imaging findings.	Intelligent Clinical Surveillance: Predicting the Risk of Patient Deterioration
Key Features	AI-driven critical finding detection (via Aidoc platform), Secure, real-time communication of findings, Customizable communication protocols, Automated follow-up tracking and reminders, Seamless integration with PACS, RIS, and EHR systems, Comprehensive audit trails for all communications, Prioritization of urgent cases for immediate attention, Mobile access for care team collaboration	AI-powered predictive analytics, Real-time patient deterioration prediction (up to 8 hours in advance), Customizable best practice clinical protocols, NotifyMe smart alerting (low alarm fatigue), Unified patient view and Unit View dashboards, Automated APACHE score documentation, Sepsis Virtual Unit (SVU), Heart Failure Virtual Unit (HFVU)
Specialties	Cardiology, Emergency Medicine, Neurology, Pulmonology, Radiology	Cardiology, Critical Care, Hospital Medicine
Target Size	Large hospitals and health systems	Not specified

Videos

Demos, reviews, and walkthroughs featuring BriefCase and CLEWICU.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing physician workflows and EHR systems?

BriefCase integrates with PACS, RIS, and EHR systems to streamline the sharing of critical medical imaging findings. CLEWICU is EHR-agnostic and collects and aggregates data from EMRs, ADT systems, patient monitoring systems, and life support devices to build real-time physiological profiles of patients.

What is the accuracy and sensitivity of each tool in detecting critical conditions or predicting patient deterioration?

BriefCase has demonstrated high sensitivity and specificity in detecting various conditions, with a mean sensitivity of 97% and specificity of 98% for newly cleared indications in abdomen CT. CLEWICU's predictive models for patient deterioration were found to be five times more accurate than alerts from a leading telemedicine system and generate significantly fewer alarms.

For which medical specialties are these tools best suited?

BriefCase is designed for specialties such as Cardiology, Emergency Medicine, Neurology, Pulmonology, and Radiology, focusing on critical medical imaging findings. CLEWICU is tailored for high-acuity care across various inpatient settings, including ICUs, EDs, and medical/surgical floors, with specialties including Cardiology, Critical Care, and Hospital Medicine.

What kind of audit trail features do these tools offer for reviewing AI-driven insights and communications?

BriefCase provides comprehensive audit trails for all communications, ensuring a record of shared critical medical imaging findings. The available information for CLEWICU does not explicitly detail its audit trail features, but it does offer reporting and benchmarking for quality improvement.

How do these tools support multi-site rollout and scalability for large health systems?

BriefCase is targeted towards large hospitals and health systems and is designed for enterprise deployment. CLEWICU is built for large, data-rich, enterprise deployments and is EHR-agnostic, facilitating seamless integration across a health system.

What is the clinical context in which each tool is intended to be used, and how does it aid physician decision-making?

BriefCase is a radiological computer-aided triage and notification software that assists in prioritizing urgent cases by flagging suspected findings in medical images, such as intracranial hemorrhage, pulmonary embolism, and cervical spine fractures. It is not a diagnostic device and its results are to be used in conjunction with other patient information and professional judgment. CLEWICU is an AI-driven clinical surveillance and predictive analytics platform that forecasts patient deterioration, such as respiratory failure and hemodynamic instability, up to eight hours in advance, providing clinicians with preemptive information for early intervention and resource optimization.